Projects

GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O - Germany 

Project overview (since 2010-01-01):

Start dateProjectacronymrolefundingpartners
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025
2016-01-01Ears, Eyes and Mind: The ‘SENSE-Cog Project’ to improve mental well-being for elderly Europeans with sensory impairment SENSE-Cogparticipant6.541.59120
2016-01-01Folate-Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis FOLSMARTparticipant4.993.83411
2016-01-01Small vessel diseases in a mechanistic perspective: Targets for Intervention Affected pathways and mechanistic exploitation for prevention of stroke and dementia SVDs-at-targetparticipant5.998.30013
2015-11-01RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities RELENTparticipant5.999.43115
2015-11-01Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A HemAcureparticipant5.564.3958
2015-07-01Diamond materials for the photocatalytic conversion of CO2 to fine chemicals and fuels using visible light DIACATparticipant3.872.9809
2015-06-01PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke PRECIOUSparticipant5.994.00017
2015-01-01Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes TREGenerationparticipant5.899.2508
2013-11-01Targets and biomarkers for antiepileptogenesis EPITARGETparticipant11.999.97518
2013-11-01Labeling of Enalapril from Neonates up to Adolescents LENAparticipant5.999.99112
2013-10-01Personalised Prognostic Tools for Early Psychosis Management PRONIAparticipant6.000.00011
2013-10-01Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope EU-CERT-ICDparticipant5.999.56219
2013-10-01Collaborative European NeuroTrauma Effectiveness Research in TBI CENTER-TBIparticipant29.998.90338
2013-10-01Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified. CFMATTERSparticipant5.999.74812
2013-09-01"MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy" EPIMIRNAparticipant11.586.85816
2013-09-01Neurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing FEMNAT-CDparticipant5.999.24117
2013-09-01Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock CULPRIT-SHOCKparticipant5.999.14517
2013-08-01New approaches in the development of Hypoallergenic implant material in Orthopaedics: steps to personalised medicine HYPORTHparticipant5.282.6008
2013-05-01Donor T Cells for Immune Control T-CONTROLparticipant5.682.5365
2013-01-01Bioactivated hierarchical hydrogels as zonal implants for articular cartilage regeneration HYDROZONESparticipant9.749.70016
2012-12-01Systems medicine of chronic inflammatory bowel disease SYSMEDIBDparticipant11.999.99812
2012-11-01Emerging mental health systems in low- and middle-income countries EMERALDparticipant5.798.17312
2012-10-01Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD) DSD-LIFEparticipant2.999.95616
2012-10-01Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and non-drug Therapy in Older peRsons SENATORparticipant5.938.94712
2012-10-01European Consortium for High-Throughput Research in Rare Kidney Diseases EURENOMICSparticipant11.994.56728
2012-09-01Resource Preservation by Application of BIOefFECTORs in European Crop Production BIOFECTORparticipant5.999.82123
2012-07-01Bottom-up reconstitution of a biomimetic bioartificial liver RE-LIVERparticipant4.234.8775
2012-02-01European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke EuroHYP-1participant10.941.66538
2012-01-01Disaster Training Curriculum DITACparticipant3.498.66813
2012-01-01A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease NILVADparticipant5.999.97817
2012-01-01EUROPEAN FORENSIC GENETICS Network of Excellence EUROFORGEN-NOEparticipant6.613.68017
2012-01-01Developmental Origins of Healthy and Unhealthy Ageing: The Role of Maternal Obesity DORIANparticipant2.999.97310
2011-12-01Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial WAKE-UPparticipant11.599.98713
2011-11-01Epilepsy Pharmacogenomics: delivering biomarkers for clinical use EpiPGXparticipant5.997.99615
2011-10-01A novel generation of skin substitutes to clinically treat a broad spectrum of severe skin defects EuroSkinGraftparticipant5.996.0188
2011-10-01Cardiovascular Risk from Exposure to Low-dose and Low-dose-rate Ionizing Radiation PROCARDIOparticipant2.998.38713
2011-10-01A Treatment-Oriented Research Project of NCL Disorders as a Major Cause of Dementia in Childhood DEM-CHILDparticipant2.998.79513
2011-02-01European Sequencing and Genotyping Infrastructure ESGIparticipant9.499.99911
2011-01-01European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults ENS@T-CANCERparticipant5.993.97816
2010-11-01Infectious triggers of chronic autoimmunity INTRICATEparticipant5.965.08612
2010-10-01Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn The HIP Trialparticipant5.355.32216